We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Dr. Reddy's Files FDA ANDA For UCB Epilepsy Drug

Law360 (March 22, 2004, 12:00 AM EST) -- Indian drug maker Dr. Reddy's Laboratories has filed an abbreviated new drug application with the United States Food and Drug Administration for levetiracetam, a generic form of Belgian pharmaceutical company UCB's epilepsy drug Keppra.

UCB has already filed a law suit against Dr.Reddy's in the U.S. district court for the District of Georgia, alleging patent infringement on the two Orange Book patents.

Dr. Reddy’s said it had made a Paragraph IV filing on the two patents in the so-called "Orange Book", which lists multiple patents on...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.